Aniridia-intellectual Disability Syndrome

Oncology·MeSH: Sensorimotor neuropathy with ataxia, autosomal dominant

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Aniridia-intellectual Disability Syndrome?

There are 1 clinical trial targeting Aniridia-intellectual Disability Syndrome tracked by BioSniper.

What is the prevalence of Aniridia-intellectual Disability Syndrome?

The estimated prevalence of Aniridia-intellectual Disability Syndrome is approximately 0.1 per 100,000 population.

Deep-dive into Aniridia-intellectual Disability Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Aniridia-intellectual Disability Syndrome — Drugs in Development & Clinical Trials | BioSniper